These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2232295)

  • 1. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
    Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
    Higaki S; Morohashi M
    Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Propionibacterium acnes lipase by extracts of Indian medicinal plants.
    Patil V; Bandivadekar A; Debjani D
    Int J Cosmet Sci; 2012 Jun; 34(3):234-9. PubMed ID: 22268921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
    Higaki S; Nakamura M; Morohashi M; Yamagishi T
    Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves.
    Saising J; Voravuthikunchai SP
    Anaerobe; 2012 Aug; 18(4):400-4. PubMed ID: 22626672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.
    Higaki S; Hasegawa Y; Morohashi M; Takayoshi Y
    J Dermatol; 1995 Jan; 22(1):4-9. PubMed ID: 7897023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-lipase activity of shiunko on Propionibacterium acnes.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T
    Int J Antimicrob Agents; 1998 Aug; 10(3):251-2. PubMed ID: 9832288
    [No Abstract]   [Full Text] [Related]  

  • 12. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components.
    Yokozawa T; Ishida A; Kashiwada Y; Cho EJ; Kim HY; Ikeshiro Y
    J Pharm Pharmacol; 2004 Apr; 56(4):547-56. PubMed ID: 15099450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of eleven kampo formulations and eight kampo crude drugs against Propionibacterium acnes isolated from acne patients: retrospective evaluation in 1990 and 1995.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 Dec; 23(12):871-5. PubMed ID: 9037918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exoenzymes of Propionibacterium acnes.
    Kabongo Muamba ML
    Can J Microbiol; 1982 Jul; 28(7):758-61. PubMed ID: 7172137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uptake and transport behavior of berberine in Coptidis Rhizoma extract through rat primary cultured cortical neurons.
    Wang X; Xing D; Wang W; Lei F; Su H; Du L
    Neurosci Lett; 2005 May; 379(2):132-7. PubMed ID: 15823430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fermentation of 1,2-O-iso-propylidene-D-glucofuranose ("monoacetone glucose") by anaerobic bacteria.
    Cmelik SH
    Zentralbl Bakteriol A; 1980; 247(4):495-501. PubMed ID: 7456850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of Coptidis Rhizoma alkaloids against peroxynitrite-induced damage to renal tubular epithelial cells.
    Yokozawa T; Satoh A; Cho EJ; Kashiwada Y; Ikeshiro Y
    J Pharm Pharmacol; 2005 Mar; 57(3):367-74. PubMed ID: 15807993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors.
    Coenye T; Peeters E; Nelis HJ
    Res Microbiol; 2007 May; 158(4):386-92. PubMed ID: 17399956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sub-lethal concentrations of the antimicrobial agent propylene phenoxetol on the growth and extracellular enzymes of Propionibacterium acnes.
    Greenman J
    Microbios; 1984; 39(156):101-8. PubMed ID: 6231455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition.
    Lee WL; Shalita AR; Suntharalingam K; Fikrig SM
    Infect Immun; 1982 Jan; 35(1):71-8. PubMed ID: 7054130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.